These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 4729926)

  • 1. Determinants of serum antipyrine half-lives in patients with liver disease.
    Branch RA; Herbert CM; Read AE
    Gut; 1973 Jul; 14(7):569-73. PubMed ID: 4729926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipyrine, paracetamol, and lignocaine elimination in chronic liver disease.
    Forrest JA; Finlayson ND; Adjepon-Yamoah KK; Prescott LF
    Br Med J; 1977 May; 1(6073):1384-7. PubMed ID: 861646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ergometric studies of body tolerance in patients with chronic liver disease].
    Franken FH; Wiechers B
    Dtsch Med Wochenschr; 1973 Mar; 98(11):528-31. PubMed ID: 4694994
    [No Abstract]   [Full Text] [Related]  

  • 4. Impaired elimination of meperidine in patients with liver disease.
    McHorse TS; Klotz U; Wilkinson G; Schenker S
    Trans Assoc Am Physicians; 1974; 87():281-7. PubMed ID: 4456737
    [No Abstract]   [Full Text] [Related]  

  • 5. Impairment of drug elimination in patients with liver disease.
    Narang AP; Datta DV; Mathur VS
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):28-32. PubMed ID: 3988389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effect of zinc supplementation on antipyrine clearance in alcoholic liver disease.
    Grønbaek K; Friis H; Feldman M; Sonne J; Andreasen PB
    Eur J Clin Pharmacol; 1996; 49(5):397-9. PubMed ID: 8866636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipyrine metabolism and liver function in patients treated with high-dose medroxyprogesterone.
    Rautio A; Kauppila AJ; Tuimala RJ; Sotaniemi EA
    Biomedicine; 1979 Sep; 31(5):135-8. PubMed ID: 508896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced serum somatomedin activity in patients with chronic liver disease.
    Wu A; Grant DB; Hambley J; Levi AJ
    Clin Sci Mol Med; 1974 Oct; 47(4):359-66. PubMed ID: 4154157
    [No Abstract]   [Full Text] [Related]  

  • 9. Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy.
    Levi AJ; Sherlock S; Walker D
    Lancet; 1968 Jun; 1(7555):1275-9. PubMed ID: 4172137
    [No Abstract]   [Full Text] [Related]  

  • 10. Microsomal enzymes in malnutrition as determined by plasma half life of antipyrine.
    Krishnaswamy K; Naidu AN
    Br Med J; 1977 Feb; 1(6060):538-40. PubMed ID: 843795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clearance of antipyrine and indocyanine green in normal subjects and in patients with chronic lever disease.
    Branch RA; James JA; Read AE
    Clin Pharmacol Ther; 1976 Jul; 20(1):81-9. PubMed ID: 1277728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of drug metabolism in patients with liver cancer.
    Sotaniemi EA; Pelkonen RO; Mokka RE; Huttunen R; Viljakainen E
    Eur J Clin Invest; 1977 Aug; 7(4):269-74. PubMed ID: 196861
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of activity in chronic active liver disease. Serum bile acids compared with conventional tests and histology.
    Korman MG; Hofmann AF; Summerskill WH
    N Engl J Med; 1974 Jun; 290(25):1399-402. PubMed ID: 4133590
    [No Abstract]   [Full Text] [Related]  

  • 14. Microsomal enzymes in patients with acute leukemia as determined by plasma half-life of antipyrine.
    Higuchi T; Nakamura T; Uchino H
    Cancer Chemother Pharmacol; 1980; 5(1):55-9. PubMed ID: 6936094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jet fuel and liver function.
    Døssing M; Loft S; Schroeder E
    Scand J Work Environ Health; 1985 Dec; 11(6):433-7. PubMed ID: 4095521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of abnormal fibrin polymerisation with severe liver disease.
    Green G; Poller L; Thomson JM; Dymock IW
    Gut; 1977 Nov; 18(11):909-12. PubMed ID: 590852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normotest in acute hepatitis and chronic liver disease.
    Ockerman PA; Braconier JH; Eriksson O
    Scand J Gastroenterol Suppl; 1973; 19():83-91. PubMed ID: 4515643
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.
    Vesell ES; Page JG
    J Clin Invest; 1969 Dec; 48(12):2202-9. PubMed ID: 5389794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Normotest and Thrombotest, coagulation tests in hepatocellular disease.
    Hillenbrand P; Sherlock S
    Scand J Gastroenterol Suppl; 1973; 19():125-31. PubMed ID: 4123935
    [No Abstract]   [Full Text] [Related]  

  • 20. "Lupoid" hepatitis, a nonentity in the spectrum of chronic active liver disease.
    Soloway RD; Summerskill WH; Baggenstoss AH; Schoenfield LJ
    Gastroenterology; 1972 Sep; 63(3):458-65. PubMed ID: 4116064
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.